Serum Insulin Assay : An Important Therapeutic Tool in Management of Freshly Diagnosed Type 2 Diabetes Mellitus

Journal of Association of Physicians of India

Volumn 48, Issue 8, 2000, Pages 815-817

  Saxena, T ^a   Maheshwari, S ^a   Goyal, R K ^a  

^a J L N MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; GLIPIZIDE; INSULIN; METFORMIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD; BLOOD PRESSURE; COMPARATIVE STUDY; DRUG EFFECT; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; MALE; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; TREATMENT OUTCOME;

ADULT; AGED; BLOOD GLUCOSE; BLOOD PRESSURE; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; GLIPIZIDE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; METFORMIN; MIDDLE AGED; TREATMENT OUTCOME; TRIGLYCERIDES;

EID: 0034252232     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Yia Jaarvinen H. Pathogenesis of non insulin dependent diabetes mellitus. Lancet 1994; 343 : 91-5.
2. Foster DW. Diabetes Mellitus. : In Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper DI, Hauser SL, Longo DL ed. Harrison's principles of internal medicine. McGraw Hill Companies United States of America. 1998; 2060-81.
3. Karam JH. Type II diabetes and syndrome X : Pathogenesis and glycemic management. Endocrinol Metab Clin North Am 1992; 21 : 329.
4. Reaven GM, Lithell H, Landsberg L. Hypertension and associated metabolic abnormalities and role of insulin resistance and sympathoadrenal system. N Engl J Med 1996; 334 : 374.
5. Noury J, Nandeuil A. Comparative three month study of the efficacies of metformin and gliclazide in the treatment of NIDDM. Diabete Metab 1991; 17 : 209-12.
6. Wildasin EM, Skaar DJ, Kirchain WR, Hulse M. Metformin, a promising oral antihyperglycemic for the treatment of noninsulin-dependent diabetes mellitus. Pharmacotherapy 1997; 17 : 62-73.
7. Nestler JE, Beer NA, Jakubowicz DJ, Beer RM. Effects of a reduction in circulating insulin by metformin on serum dehydroepiandrosterone sulfate in nondiabetic men. J Clin Endocrinol Metab 1994; 78 : 549-54.
8. Bailey CJ, Turner RC. Metformin. N Engl J Med 1996; 334 : 574.
9. Landin K, Tengborn L, Smith U. Treating insulin resistance in hypertension with metformin decreases both blood pressure and metabolic risk factors. J Intern Med 1991; 229 : 181-7.
10. Grosskopf I, Ringel Y, Charach G, Maharashak N, Mor R, Iaina A, Weintraub M. Metformin enhances clearance of chylomicrons and chylomicron remnants in nondiabetic mildly overweight glucose-intolerant subjects. Diabetes Care 1997; 20 : 1598-602.